Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation

[1]  J. Kyula,et al.  Targeted radiosensitization by the Chk1 inhibitor SAR-020106. , 2013, International journal of radiation oncology, biology, physics.

[2]  Tania L. Slatter,et al.  Telomere Profiling: Toward Glioblastoma Personalized Medicine , 2013, Molecular Neurobiology.

[3]  S. Trapasso,et al.  Cancer stem cells in head and neck cancer , 2012, OncoTargets and therapy.

[4]  Dominique Ardail,et al.  Glutathione Depletion and Carbon Ion Radiation Potentiate Clustered DNA Lesions, Cell Death and Prevent Chromosomal Changes in Cancer Cells Progeny , 2012, PloS one.

[5]  O. Yokosuka,et al.  Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  S. Trapasso,et al.  Role of CD44 as a marker of cancer stem cells in head and neck cancer , 2012, Biologics : targets & therapy.

[7]  E. Choi,et al.  All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway. , 2012, European journal of cancer.

[8]  R. Caltabiano,et al.  Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status , 2012, World Journal of Surgical Oncology.

[9]  Dominique Ardail,et al.  Targeting a cornerstone of radiation resistance: cancer stem cell. , 2012, Cancer letters.

[10]  H. Pyo,et al.  Celecoxib enhances the radiosensitizing effect of 7-hydroxystaurosporine (UCN-01) in human lung cancer cell lines. , 2012, International journal of radiation oncology, biology, physics.

[11]  Alysha K Croker,et al.  Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells , 2012, Breast Cancer Research and Treatment.

[12]  Tadashi Kamada,et al.  Results of carbon ion radiotherapy for head and neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  H. Tsujii,et al.  Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. , 2012, International journal of radiation oncology, biology, physics.

[14]  D. Hwang,et al.  CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. , 2012, Cancer letters.

[15]  A. Giatromanolaki,et al.  Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer , 2012, British Journal of Cancer.

[16]  J. Debus,et al.  In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells , 2012, Radiation oncology.

[17]  E. Cohen,et al.  Current Treatment Options for Metastatic Head and Neck Cancer , 2012, Current Treatment Options in Oncology.

[18]  J. Mi.  Current treatment strategy of acute promyelocytic leukemia , 2011, Frontiers of medicine.

[19]  R. Okayasu,et al.  Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. , 2011, Cancer research.

[20]  Dominique Ardail,et al.  Transient Alteration of Cellular Redox Buffering before Irradiation Triggers Apoptosis in Head and Neck Carcinoma Stem and Non-Stem Cells , 2011, PloS one.

[21]  M. Wicha,et al.  Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. , 2010, Cancer research.

[22]  Mengzhong Liu,et al.  Chk1 inhibitor Gö6976 enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy and chemotherapy in vitro and in vivo. , 2010, Cancer letters.

[23]  M. Ljungman.  The DNA damage response—Repair or despair? , 2010, Environmental and molecular mutagenesis.

[24]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[25]  Guang-Yuh Chiou,et al.  Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. , 2010, Oral oncology.

[26]  F. Bertucci,et al.  Retinoid signaling regulates breast cancer stem cell differentiation , 2009, Cell cycle.

[27]  Yi-Wei Chen,et al.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.

[28]  M. Beuve,et al.  Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays. , 2009, International journal of radiation oncology, biology, physics.

[29]  Deborah Citrin,et al.  In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase , 2009, Clinical Cancer Research.

[30]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[31]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[32]  M. Beuve,et al.  Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions. , 2008, International journal of radiation oncology, biology, physics.

[33]  A. Jimeno,et al.  Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors , 2008, Cancer Chemotherapy and Pharmacology.

[34]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[35]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[36]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[37]  H. Tsujii,et al.  Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[38]  Ping Wu,et al.  Effects of All-trans Retinoic Acid (ATRA) on Human Myeloma Cells , 2003, Leukemia & lymphoma.

[39]  L. Playle,et al.  Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines , 2002, British Journal of Cancer.

[40]  F. Recchia,et al.  Ifosfamide, cisplatin, and 13‐Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck , 2001, Cancer.

[41]  H. Tsujii,et al.  High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. , 2001, International journal of radiation oncology, biology, physics.

[42]  K. Trott.  Cell repopulation and overall treatment time. , 1990, International journal of radiation oncology, biology, physics.

[43]  M. Herlyn,et al.  Stem-like cells and therapy resistance in squamous cell carcinomas. , 2012, Advances in pharmacology.

[44]  Z. Karabekian,et al.  Stem Cell Rev and Rep , 2010 .

[45]  R. Arceci.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2008 .

[46]  M. Lippman,et al.  Breast Cancer Research and Treatment , 2004, Breast Cancer Research and Treatment.

[47]  G. Steel,et al.  Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. , 1979, International journal of radiation oncology, biology, physics.